Location: Home
  • search
  • go
  • Relate News
  • 5/3/2018Novartis Gains Chinese Approval for Its RVO Drug Lucentis (ranibizumab...
  • 5/2/2018CMBA Publishes Quality Control Standard of CAR-T for Public Comments
  • 4/30/2018IP Concerns Hamper China R&D
  • 4/30/2018FDA Warns Chinese API Producer for Data Integrity and Other cGMP Viola...
  • 4/30/2018WuXi Biologics to Build Largest Biomanufacturing Facility in Ireland
  • 4/30/2018Central Government Issues New Policy to Reduce Value-Added Tax of Anti...
  • 4/30/2018CNDA Grants Conditional Approval of MSD's HPV Vaccine Gardasil 9
  • 4/27/2018CDE Issues Rules and Standards for Fast Reporting of Safety Data Durin...
  • 4/27/2018WuXi STA to Build New R&D Center in Shanghai
  • 4/27/2018Recent Executive Moves
  • 4/27/2018CDE Seeks Comments on New Rule for BE Study Samples of Chemical Generi...
  • 4/27/2018HKU Scientists Invent Universal Antibody Drug against HIV/AIDS
  • 4/26/2018CNDA Solicits Comments on Draft Implementation Rules for Drug Test Dat...
  • 4/26/2018CNDA Announces Relevant Matters on Custom Clearance of Import Chemical...
  • 4/26/2018CNDA Issues New Technical Guidelines for Compatibility Study of Chemic...
  • 4/26/2018UCB Announces Filing Acceptance with the CNDA for RA Drug CIMZIA
  • 4/25/2018MSD's HPV Vaccine Gardasil 9 under Review in China
  • 4/24/201830 Listed Chinese Pharma Cos Spent Over CNY 1B on Sales in 2017
  • 4/24/2018Chinese PD Hospital Drug Market on Steady Growth of 10% CAGR 2013-2017
  • 4/24/2018CPA Releases Topline Data of 2017 Hospital Drug Purchase Audit
  • 4/24/2018China Announces Import Tariff Reduction of Some Drugs including Antica...
  • 4/24/2018CNDA Issues Announcement over Matters Related to Import of APIs and Ex...
  • 4/24/20181/3 of Listed Chinese Pharma Cos Invested Over CNY 100M into R&amp...
  • 4/24/2018EpimAb and Zhejiang Teruisi Biopharma to Co-develop FIT012 Bispecific ...
  • 4/24/2018CBT and CrystalGenomics Announce Partnership to Co-develop I/O Therapy
  • 4/24/2018Merck Group Receives Patent for CRISPR Technology in China
  • 4/24/2018Simcere, Hitgen Enter Partnership and License for New Drug Discovery
  • 4/24/2018The Biosimilar Race in China
  • 4/23/2018China-Denmark Drug Regulatory Thematic Seminar held in Beijing
  • 4/19/2018Tocagen Licenses Greater China Rights for Phase III Cancer Immunothera...
  • Page:178/371 Total number of articles:11127: [First][<<] [176] [177] [178] [179] [180] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group